Antibiotic-resistant invasive pneumococcal clones in Italy

Journal of Clinical Microbiology

Volumn 45, Issue 2, 2007, Pages 306-312

  Gherardi, Giovanni ^a   Fallico, Loredana ^b   Del Grosso, Maria ^c   Bonanni, Federica ^a   D'Ambrosio, Fabio ^c   Manganelli, Riccardo ^b   Palù, Giorgio ^b   Dicuonzo, Giordano ^a   Pantosti, Annalisa ^c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

7 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; PENICILLIN BINDING PROTEIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLONE; DENMARK; GENE DELETION; GREECE; ITALY; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; NONHUMAN; NUCLEOTIDE SEQUENCE; PBP2B GENE; PBP2X GENE; PORTUGAL; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; SWEDEN; UNITED KINGDOM; XPT GENE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; ELECTROPHORESIS, GEL, PULSED-FIELD; ITALY; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PENICILLIN RESISTANCE; PENICILLIN-BINDING PROTEINS; PENICILLINS; PNEUMOCOCCAL INFECTIONS; RESTRICTION MAPPING; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 33847014762     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01229-06     Document Type: Article

References (31)

1. Albrich, W., D. Monnet, and S. Harbarth. 2004. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg. Infect. Dis. 10:514-517.
2. Boccia, D., S. Spila Alegiani, A. Pantosti, M. L. Moro, and G. Traversa. 2004. The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy. Eur. J. Pharmacol. 60:115-119.
3. Brueggemann, A., D. Griffiths, E. Meats, T. Peto, D. Crook, and B. Spratt. 2003. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 187:1424-1432.
4. Camilli, R., E. Pettini, M. Del Grosso, G. Pozzi, A. Pantosti, and M. Oggioni. 2006. Zinc metalloproteinase genes in clinical isolates of Streptococcus pneumoniae: association of the full array with a clonal cluster comprising serotypes 8 and 11A. Microbiology 152:313-321.
5. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Del Grosso, M., F. Iannelli, C. Messina, M. Santagati, N. Petrosillo, S. Stefani, G. Pozzi, and A. Pantosti. 2002. Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40:774-778.
7. Dicuonzo, G., G. Gherardi, R. E. Gertz, F. D'Ambrosio, A. Goglio, G. Lorino, S. Recchia, A. Pantosti, and B. Beall. 2002. Genotypes of recent invasive pneumococcal isolates recovered from Italian patients. J. Clin. Microbiol. 40:3660-3665.
8. Diggle, M. A., and S. C. Clarke. 2005. Truncated xpt gene present in invasive Streptococcus pneumoniae may have implications for MLST schemes. J. Med. Microbiol. 54:909-912.
9. Dowson, C. G., A. Hutchison, J. A. Brannigan, R. C. George, D. Hansman, J. Linares, A. Tomasz, J. M. Smith, and B. G. Spratt. 1989. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc. Natl. Acad. Sci. USA 86:8842-8846.
10. Enright, M. C., and B. G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
11. Gherardi, G., M. Del Grosso, A. Scotto d'Abusco, F. D'Arabrosio, G. Dicuonzo, and A. Pantosti. 2003. Phenotypic and genotypic characterization of two penicillin-susceptible serotype 6B Streptococcus pneumoniae clones circulating in Italy. J. Clin. Microbiol. 41:2855-2861.
12. Gherardi, G., J. S. Inostrozo, M. O'Ryan, V. Prado, S. Prieto, C. Arellano, R. R. Facklam, and B. Beall. 1999. Genotypic survey of recent beta-lactam-pneumococcal nasopharyngeal isolates from asymptomatic children in Chile. J. Clin. Microbiol. 37:3725-3730.
13. Gherardi, G., C. G. Whitney, R. R. Facklam, and B. Beall. 2000. Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J. Infect. Dis. 181:216-229.
14. Gonzalez, B., K. Hulten, L. Lamberth, S. Kaplan, E. J. Mason, and the U.S. Pediatric Multicenter Pneumococcal Surveillance Group. 2006. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr. Infect. Dis. J. 25:301-305.
15. Gruppo di Lavoro ICONA. 2003. ICONA 2003: indagine nazionale sulla copertura vaccinale infantile. Rapporti ISTISAN 03/37. Istituto Superiore di Sanità, Rome, Italy.
16. Hausdorff, W. P., J. Bryant, P. R. Paradiso, and G. R. Siber. 2000. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 30:100-121.
17. Henrichsen, J. 1995. Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33:2759-2762.
18. Henriques Normark, B., M. Kalin, A. Ortqvist, T. Akerlund, B. Liljequist, J. Hedlund, S. Svenson, J. Zhou, B. Spratt, S. Normark, and G. Kallenius. 2001. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J. Infect. Dis. 184:861-869.
19. Huang, S., R. Platt, S. Rifas-Shiman, S. Pelton, D. Goldmann, and J. Finkelstein. 2005. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116:408-413.
20. Kyaw, M., R. Lynfield, W. Schaffner, A. Craig, J. Hadler, A. Reingold, A. Thomas, L. Harrison, N. Bennett, M. Farley, R. Facklam, J. Jorgensen, J. Besser, E. Zell, A. Schuchat, C. Whitney, and the Active Bacterial Core Surveillance of the Emerging Infections Program Network. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354:1455-1463,
21. Marchese, A., L. Gualco, I. Cochetti, M. Montanari, A. Speciale, S. Musumeci, P. Varaldo, G. Nicoletti, and G. Schito. 2005. Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). Int. J. Antimicrob. Agents 26:138-145.
22. McGee, L., L. McDougal, J. Zhou, B. G. Spratt, F. C. Tenover, R. George, R. Hakenbeck, W. Hryniewicz, J. C. Lefevre, A. Tomasz, and K. P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565-2571.
23. Monaco, M., R. Camilli, F. D'Ambrosio, M. Del Grosso, and A. Pantosti. 2005. Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy. J. Antimicrob. Chemother. 55:256-259.
24. Obaro, S. K., M. A. Monteil, and D. C. Henderson. 1996. Fortnigtly review: the pneumococcal problem. BMJ 312:1521-1525.
25. Pai, R., M. Moore, T. Pilishvili, R. Gertz, C. Whitney, B. Beall, and the Active Bacterial Core Surveillance Team. 2005. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192:1988-1995.
26. Pantosti, A., D. Boccia, F. D'Ambrosio, S. Recchia, G. Orefici, M. More, the National Surveillance of Bacterial Meningitis, and the EARSS-Italia groups. 2003. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of isolates from invasive diseases. Microb. Drug Resist. 9:S61-S68.
27. Pantosti, A., G. Gherardi, M. Conte, F. Faella, G. Dicuonzo, and B. Beall. 2002. A novel, multiple drug-resistant, serotype 24F strain of Streptococcus pneumoniae that caused meningitis in patients in Naples, Italy. Clin. Infect. Dis. 35:205-208.
28. Pneumococcal Molecular Epidemiology Network. 15 October 2006, posting date. [Online.] http://www.sph.emory.edu/PMEN/pmen_done_collection.html. PMEN, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA.
29. Saxild, H. H., and P. Nygaard. 1987. Genetic and physiological characterization of Bacillus subtilis mutants resistant to purine analogs. J. Bacteriol. 169:2977-2983.
30. Scott, J. A. G., A. J. Hall, R. Dagan, J. M. S. Dixon, S. J. Eykyn, A. Ferioll, M. Hortal, L. P. Jetté, J. H. Jorgensen, F. Lamothe, C. Latorre, J. T. Macfarlane, D. M. Shlaes, L. E. Smart, and A. Taunay. 1996. Serogroup-specific epidemiology of Streptococcus pneumoniae: association with age, sex, and geography in 7,000 episodes of invasive disease. Clin. Infect. Dis. 22: 973-981.
31. Whitney, C. G., M. Farley, J. Hadler, L. Harrison, N. Bennett, R. Lynfield, A. Reingold, P. Cieslak, T. Pilishvili, D. Jackson, R. R. Facklam, J. H. Jorgensen, A. Schuchat, and the Active Bacterial Core Surveillance of the Emerging Infections Program Network. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746.